source
- Cue Biopharma's chronic hives drug clears Phase 2 trial, first immunology data after cancer pivotCue Biopharma announced that its candidate for chronic spontaneous urticaria successfully completed a Phase 2 trial in China. The trial marks the company's first clinical data since it shifted its…
- Addiction clinics see rising cases of kratom and 7-OH withdrawalAddiction clinics are seeing a surge in patients dependent on potent kratom and 7-OH products.